Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
about
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.The β-blocker Nebivolol Is a GRK/β-arrestin biased agonistA novel therapy to attenuate acute kidney injury and ischemic allograft damage after allogenic kidney transplantation in miceβ3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells.Neurohormonal interactions on the renal oxygen delivery and consumption in haemorrhagic shock-induced acute kidney injury.Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.Effects of serelaxin on renal microcirculation in rats under control and high-angiotensin environments.Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.The usefulness of carvedilol and nebivolol in preventing contrast nephropathy in rats.Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications.
P2860
Q30491698-FE308B85-829A-40BE-A95F-07E7D2C81C62Q34972784-532801C3-9717-4ED8-94AC-E84E3387F9D6Q35008936-502F569E-9BA5-4766-B4C2-4AE9E30A5CB1Q36714097-DE07D044-1A23-4B75-9450-842F745F4564Q37629199-ABE38545-F0CB-4A34-8382-EA67F508540BQ38120300-02AAD408-8498-4053-87D6-815C773AA038Q38778217-6818B6C0-8085-467B-9B8A-B4AF4D758DE2Q39080324-7DE26F0A-133F-480F-A9C1-DB9ED6A3051DQ47619900-0FA2F962-1F2A-4DF6-9954-6951F9DA1847Q48369805-5A8A5637-9107-45B7-8BCB-41DBA0A22B7BQ53638881-60CF13A3-5DCD-43EB-908A-63EC87F915A5Q54981618-82E0F907-636A-49C3-88B5-E3B9DD19E423
P2860
Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Nebivolol-induced vasodilation ...... ric oxide synthase activation.
@en
Nebivolol-induced vasodilation ...... ric oxide synthase activation.
@nl
type
label
Nebivolol-induced vasodilation ...... ric oxide synthase activation.
@en
Nebivolol-induced vasodilation ...... ric oxide synthase activation.
@nl
prefLabel
Nebivolol-induced vasodilation ...... ric oxide synthase activation.
@en
Nebivolol-induced vasodilation ...... ric oxide synthase activation.
@nl
P2093
P2860
P1476
Nebivolol-induced vasodilation ...... ric oxide synthase activation.
@en
P2093
L Gabriel Navar
Ming-Guo Feng
Minolfa C Prieto
P2860
P304
P356
10.1152/AJPRENAL.00233.2012
P577
2012-06-06T00:00:00Z